![Crude oil settles lower, but bags 2-week win streak as demand outlook improves](https://i-invdn-com.investing.com/news/LYNXNPEC0L0I7_S.jpg)
Please try another search
MAIA Biotechnology, Inc., a targeted therapy, immuno-oncology company, focuses on the development and commercialization of drugs with novel mechanisms of action that are intended to improve and extend the lives of people with cancer. Its lead program is THIO, a potential cancer telomere targeting agent in clinical development for the treatment of NSCLC patients with telomerase-positive cancer cells. The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
Name | Age | Since | Title |
---|---|---|---|
Steven M. Chaouki | 49 | 2021 | Independent Director |
Ramiro Guerrero | 56 | - | Independent Director |
Cristian Luput | 47 | - | Independent Director |
Jerry W. Shay | - | 2021 | Chairman of Scientific Advisory Board |
Ngar Yee Louie | 56 | 2020 | Independent Director |
Vlad Vitoc | 52 | - | Co-Founder, President, CEO & Chairman of the Board of Directors |
Stan V. Smith | 75 | - | Lead Independent Director |
Tudor Ciuleanu | - | 2021 | Member of Scientific Advisory Board |
David M. Ashley | - | 2021 | Member of Scientific Advisory Board |
Z. Gunnur Dikmen | - | 2021 | Member of Scientific Advisory Board |
Adam Yopp | - | 2021 | Member of Scientific Advisory Board |
Jean-Manasse Theagene | 57 | 2023 | Independent Director |
Remus Vezan | - | 2024 | Scientific Advisory Board |
Saadettin Kilickap | - | 2024 | Member of Scientific Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review